15.5. Analysis.

Comparison 15 BPO/clindamycin versus adapalene, Outcome 5 Percentage of participants with any adverse events (long‐term data).

Comparison 15 BPO/clindamycin versus adapalene, Outcome 5 Percentage of participants with any adverse events (long‐term data).